Nucleic Acid Standards for Biosecurity Act (H.R. 3029)
Referred to CommitteeTo amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Latest Action
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
7/21/2026 • Senate
Summary
Nucleic Acid Standards for Biosecurity Act
This bill explicitly requires the National Institute of Standards and Technology (NIST) to support the development of best practices and technical standards for nucleic acid synthesis.
Nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), carry genetic information within cells. Nucleic acid synthesis is the process of designing and creating custom nucleic acids; it is used in the development of medications and agricultural products. However, this technology also poses a risk of misuse (e.g., the intentional or unintentional creation of dangerous biological agents).
The bill requires NIST to carry out measurement research to support the development and improvement of biosecurity best practices and technical standards related to nucleic acid synthesis. This effort must address specified topics including nucleic acid synthesis screening, operational security, and conformity assessment. (A 2023 executive order titled Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence directed NIST to develop and refine similar specifications and best practices for use by synthetic nucleic acid providers. NIST's work on this topic is ongoing.)
In carrying out this effort, NIST must convene stakeholders to develop and periodically update consensus priorities and best practices for synthetic nucleic acid screening mechanisms. Within a specified period, NIST must submit a summary of the stakeholder group’s findings to Congress.
NIST must also take steps to advance risk management best practices and technical standards for engineering biology and biomanufacturing, including with respect to risks associated with the use of artificial intelligence.
Introduced in House • 4/28/2025
Topics & Subjects
CBO Cost Estimates (1)
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (4)
Party Breakdown
Sponsor
Cosponsors (3)
Bill Journey
Originated in the House
Introduced
April 28, 2025
Committee Review
April 29, 2025
Ordered to be Reported by Voice Vote.
Floor Debate
July 20, 2026
Passed Chamber
July 20, 2026
Other Chamber
President
Enacted into Law
Text Versions (4)
Committee Reports (1)
Committees
Details
Sources and method
· Congress.gov, CRS, CBO, USAspending, FEC, LDA · Record updated Nov 17, 2026
- Congress.govLibrary of CongressStatus, actions, sponsors, cosponsors, committees and textRecord updated Nov 17, 2026 · Loaded Nov 17, 2026, 7:59 PM ET
- CRS bill summaryCongressional Research Service, via Congress.govOfficial summarySummary of the “Introduced in House” version, Apr 28, 2025 · Loaded Nov 17, 2026, 7:59 PM ET
- CBO cost estimatesCongressional Budget OfficeCost estimatesLatest estimate Jun 24, 2025 · Loaded Nov 17, 2026, 7:59 PM ET
- USAspending.govU.S. Department of the TreasuryRelated Federal Spending section
- FEC filingsFederal Election CommissionFunding & Lobbying section
- Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the HouseFunding & Lobbying section
All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →
AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →
Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.